ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage

Harsh Patel(SUNY Upstate Medical University), Ying Huang(Hohai University)
Cell Death and Disease
July 17, 2020
Cited by 9


Related Papers